Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Creative Proteomics Cytokine Launches Growth Factors (GF) Detection Service for Your Research

    Dec 27, 2022, 11:09 AM by
    Full story
  • Creative Proteomics Launches SPR-based Biacore Service to Help Study Biomolecular Interactions

    Dec 27, 2022, 11:02 AM by
    Full story
  • CRISPR Off-Target Analysis Now Available with CD Genomics’ Bioinformatics-Analysis Platform

    Dec 27, 2022, 11:01 AM by
    Full story
  • CD Genomics RNA-Solutions Platform Unveils m7G MeRIP Sequencing for Scientific Research

    Dec 27, 2022, 10:56 AM by
    Full story
  • Alfa Chemistry Commenced Offering PTFE (Polytetrafluoroethylene), Optical Fibers, and Diamond Raw Materials

    Dec 27, 2022, 10:45 AM by
    Full story
  • Startup OncoDxRx harnesses the power of proprietary liquid biopsy technologies for better clinical diagnostics and therapeutics

    Dec 27, 2022, 10:43 AM by
    New Startup OncoDxRx showcases its one-of-a-kind Dx technologies for oncology market
    Full story
  • Vizgen’s Terry Lo on Creating Maps of Biology’s Backroads

    Dec 27, 2022, 09:20 AM by User Not Found
    Bio-IT World | On the latest episode of the Trends from the Trenches podcast, Lo speaks with BioTeam’s Stan Gloss about spatial biology, why it matters, and how he imagines the technology changing healthcare’s future.
    Full story
  • Gene Editing in 3D Patient-Derived Tumor Organoids, Machine Learning Model As Diabetes Prevention Tool, More

    Dec 27, 2022, 01:00 AM by User Not Found
    Bio-IT World | A novel mechanism for platelet activation in pathogenic blood clotting is also believed to limit inflammation during sepsis; supercomputing and AI resources apply large language models to track how a virus mutates into more dangerous or transmissible variants; Amazon Web Services to create, fund, and build 10 successful start-up companies based out of UNC-Chapel Hill; and more.
    Full story
  • Creative Enzymes Offers Personalized and Customized Probiotic Blends

    Dec 23, 2022, 09:18 AM by
    Full story
  • Creative Enzymes Introduces Cloning Enzymes for Molecular Biology Research

    Dec 23, 2022, 09:18 AM by
    Full story
  • Oxygen-, Nitrogen-, Carbon-Donor Ligands for Coordination Chemistry Research

    Dec 23, 2022, 09:17 AM by
    Full story
  • Protection Reagents, Environmental Goods Standards, Porphyrins and Phthalocyanines

    Dec 23, 2022, 09:17 AM by
    Full story
  • Alfa Chemistry Celebrates Thanksgiving Day and Christmas with Festival Sale for All Products and Services

    Dec 23, 2022, 09:17 AM by
    Full story
  • API Supply Enriched by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

    Dec 23, 2022, 09:16 AM by
    Full story
  • Nearly 480 Cosmetic Ingredients Are Now Available at CD Formulation

    Dec 23, 2022, 09:15 AM by
    Full story
  • Follow the Money: AI-Fueled Endoscopic Procedure Recording, New Computational Biological Center for Neurodegenerative Disease, More

    Dec 22, 2022, 01:00 AM by User Not Found
    Bio-IT World | Funding for targeted cancer treatment AI platform, oligo-conjugated antibodies and nucleic acid-encoded pixels to identify and spatially locate cell surface proteins, life sciences SaaS solutions, and more.
    Full story
  • Killing Cancer With Synthetic Lethality

    Dec 21, 2022, 01:00 AM by User Not Found
    Bio-IT World | A key member of the team that discovered the BRCA2 breast cancer susceptibility gene in 1995 is now enamored of the idea of taking on cancer with synthetic lethal therapies, a nontraditional approach that exploits the weaknesses of cancer cells. The promise of the treatment concept was the topic of the Heath Memorial Award keynote address delivered at the recent Leading Edge of Cancer Research Symposium of the University of Texas MD Anderson Cancer Center.
    Full story
  • Blue Spark Technologies Touts Growth for Company and Remote Patient Monitoring Industry

    Dec 20, 2022, 12:31 PM by
    Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, celebrated a successful year of achievements with its continuous temperature monitoring solution TempTraq®. Numerous studies were released this year showing the positive impact of TempTraq in oncology clinical trials and outpatient settings.
    Full story
  • Teachable Neurons Could Improve Preclinical Drug Screening

    Dec 20, 2022, 01:00 AM by User Not Found
    Bio-IT World | When sent electrical signals, a living model of the brain succeeded in “playing” Pong, a simple, tennis-like computer game popular in the 1970s. It was a notable feat for a single layer of neural cells in a dish, recapitulating how a real brain functions better than a computer or artificial intelligence ever will.
    Full story
  • Energy reduction measures including AI are now needed to avoid energy shortage in 2023!

    Dec 19, 2022, 12:21 PM by
    Arloid Automation welcomes the new partnership between the UK and the USA (announced December 2022) to drive down energy prices but really it’s a reduction in energy consumption that’s needed to meet demand in 2023.
    Full story
  • «
  • 121
  • 122
  • 123
  • 124 (current)
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy